United Capital Financial Advisers LLC increased its stake in shares of Iqvia Holdings Inc (NYSE:IQV) by 42.1% during the first quarter, according to the company in its most recent filing with the SEC. The fund owned 6,253 shares of the medical research company’s stock after acquiring an additional 1,854 shares during the period. United Capital Financial Advisers LLC’s holdings in Iqvia were worth $613,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors also recently modified their holdings of IQV. Focused Wealth Management Inc acquired a new position in shares of Iqvia during the 4th quarter valued at about $166,000. Kendall Capital Management bought a new stake in Iqvia during the 4th quarter valued at approximately $224,000. Pitcairn Co. bought a new stake in Iqvia during the 4th quarter valued at approximately $230,000. Signition LP bought a new stake in Iqvia during the 1st quarter valued at approximately $236,000. Finally, Bbva Compass Bancshares Inc. bought a new stake in Iqvia during the 4th quarter valued at approximately $257,000. 89.83% of the stock is currently owned by institutional investors and hedge funds.
In other Iqvia news, Director Michael J. Evanisko sold 815 shares of the firm’s stock in a transaction that occurred on Wednesday, April 18th. The stock was sold at an average price of $100.00, for a total value of $81,500.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, major shareholder Cpp Investment Board Private H sold 9,291,036 shares of the firm’s stock in a transaction that occurred on Friday, June 15th. The stock was sold at an average price of $103.00, for a total value of $956,976,708.00. The disclosure for this sale can be found here. Insiders sold a total of 10,825,247 shares of company stock valued at $1,115,016,428 in the last quarter. Corporate insiders own 6.00% of the company’s stock.
Shares of IQV stock opened at $98.70 on Thursday. The company has a quick ratio of 1.16, a current ratio of 1.16 and a debt-to-equity ratio of 1.22. Iqvia Holdings Inc has a 12 month low of $87.45 and a 12 month high of $110.67. The company has a market capitalization of $20.78 billion, a price-to-earnings ratio of 22.64, a PEG ratio of 1.68 and a beta of 0.64.
Iqvia (NYSE:IQV) last announced its quarterly earnings data on Wednesday, May 2nd. The medical research company reported $1.34 EPS for the quarter, topping the Zacks’ consensus estimate of $1.27 by $0.07. Iqvia had a return on equity of 13.35% and a net margin of 13.07%. The company had revenue of $2.56 billion during the quarter, compared to the consensus estimate of $2.42 billion. The company’s quarterly revenue was up 34.1% compared to the same quarter last year. equities research analysts forecast that Iqvia Holdings Inc will post 5.07 EPS for the current year.
Several analysts recently weighed in on the company. Zacks Investment Research upgraded Iqvia from a “strong sell” rating to a “hold” rating in a research note on Friday, March 23rd. ValuEngine downgraded Iqvia from a “buy” rating to a “hold” rating in a research note on Tuesday, April 3rd. SunTrust Banks upgraded Iqvia from a “hold” rating to a “buy” rating in a research note on Wednesday, March 7th. Goldman Sachs Group upgraded Iqvia from a “neutral” rating to a “buy” rating in a research note on Friday, April 13th. Finally, Argus increased their target price on Iqvia from $110.00 to $112.00 and gave the company a “buy” rating in a research note on Monday, April 9th. Seven investment analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the company. The stock has an average rating of “Buy” and a consensus price target of $110.47.
IQVIA Holdings Inc provides integrated information and technology-enabled healthcare services in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Commercial Solutions, Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offers a range of cloud-based applications and related implementation, real-world insights, and reference information services; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services.
Want to see what other hedge funds are holding IQV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Iqvia Holdings Inc (NYSE:IQV).
Receive News & Ratings for Iqvia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Iqvia and related companies with MarketBeat.com's FREE daily email newsletter.